Floral delivery

Why Azitra is engineering bacteria to address a root cause of eczema

Instability and poor penetration can make topical delivery of proteins and peptides into the skin inefficient and inconsistent. Azitra Inc. is using an engineered human commensal strain of bacteria to consistently deliver therapeutic proteins to the skin.

Azitra’s delivery technology uses Staphylococcus epidermidis to produce steady levels of the desired protein and attaches a penetration-enhancing peptide to the protein.

CSO Travis Whitfill said S. epidermidis colonizes skin well

Read the full 665 word article

User Sign In